+30.4%
GSK vs STT
+75.3%
-44.9%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | STT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | +0.2% | -2.1% | -1.9% |
| 7D | -1.8% | +0.5% | -2.3% | -1.9% |
| 30D | -2.2% | +3.9% | -6.0% | -2.6% |
| 3M | -1.8% | +20.0% | -21.8% | -4.0% |
| 6M | -10.6% | +55.3% | -65.9% | -15.2% |
| YTD | +4.4% | +53.3% | -48.9% | -0.5% |
| 1Y | +30.4% | +74.7% | -44.3% | +27.8% |
| All | +30.4% | +75.3% | -44.9% | +27.8% |
Cumulative growth
Daily Returns
Daily percentage return beside STT.
Daily Out/Under-Performance
Portfolio return minus STT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × STT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded STT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling